purposes of the study, the New Drug Applications (NDAs) and Therapeutic Biologic Applications (BLAs) approved by the United States Food and Drug Administration (USFDA) from 2004 to 2013 were considered
enthusiasm (balanced) (7 questions), longing (7 questions), and physical activity dependence questionnaire of Hasen Blas and colleagues (2004) consists of 26 questions and six subscales. Data analysis was performed using
REMS) and required post-marketing studies to collect real-world evidence to support NDAs/BLAs (FDAAA 2007). EMA has also introduced the new Good Vigilance Practice (GVP), which replaces
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.